Human skin proteases. Separation and characterization of two acid proteases resembling cathepsin B1 and cathepsin D and of an inhibitor of cathepsin B1
- PMID: 8017
- DOI: 10.1007/BF00561502
Human skin proteases. Separation and characterization of two acid proteases resembling cathepsin B1 and cathepsin D and of an inhibitor of cathepsin B1
Abstract
Two acid proteases, one hydrolysing hemoglobin and the other hydrolysing benzoyl arginine naphthyamide (BANA), were separated and partially purified from human skin buffer extract. The acid protease hydrolysing hemoglobin was purified about 190 fold by Sephadex G-100 gel filtration and DEAE-cellulose chromatography. It hydrolysed hemoglobin at pH 3.5, casein at pH 5.8 and skin protein substrate at pH 6.0. It did not markedly hydrolyse synthetic protease substrates. The molecular size of this protease was 38000. The protease was insensitive to common protease modifiers and closely resembles cathepsin D purified from other organs. The BANA-hydrolysing acid protease was purified about 760 fold by Sephadex G-100 gel filtration and affinity chromatography on organomercurial Sepharose 4B gel. It preferentially hydrolysed BAEE, BANA and BAA with an optimum at pH 5.8. The hydrolysis of BAPA, LeuNA and protein substrates was very low. This acid protease was found to be highly dependent on reducing agents, as DTT, and chelating agents, as EDTA, and was inhibited by pCMB and TLCK. The molecular size of the enzyme was 28000. This protease closely resembles cathepsin B1 purified from other organs. Human skin was also shown to contain a low activity of benzoyl arginine amide (BAA) hydrolysing acid protease with a molecular size of about 50000 and resembling cathepsin B2. Human skin contained an inhibitor with a molecular size of about 13000 against human skin cathepsin B1. This inhibitor did not inhibit trypsin, chymotrypsin or skin proteases other than cathepsin B1.
Similar articles
-
Human skin proteases. Fractionation of psoriasis scale proteases and separation of a plasminogen activator and a histone hydrolysing protease.Arch Dermatol Res (1975). 1976 Aug 27;256(2):113-26. doi: 10.1007/BF00567358. Arch Dermatol Res (1975). 1976. PMID: 9031
-
Human skin proteases: separation and characterization of two alkaline proteases, one splitting trypsin and the other chymotrypsin substrates.Arch Dermatol Res (1975). 1975 Oct 29;253(3):261-76. doi: 10.1007/BF00561152. Arch Dermatol Res (1975). 1975. PMID: 1200704
-
Alpha-N-benzoylarginine-2-naphthylamide hydrolase (cathepsin B1?) from rat skin. I. Preliminary experiments with skin extract.Acta Chem Scand B. 1975;29(6):671-6. doi: 10.3891/acta.chem.scand.29b-0671. Acta Chem Scand B. 1975. PMID: 242171
-
Purification and biochemical characterization of rat skin cathepsin D.J Invest Dermatol. 1975 Sep;65(3):272-8. doi: 10.1111/1523-1747.ep12598339. J Invest Dermatol. 1975. PMID: 239989
-
Biguanide is a modifiable pharmacophore for recruitment of endogenous Zn2+ to inhibit cysteinyl cathepsins: review and implications.Biometals. 2019 Aug;32(4):575-593. doi: 10.1007/s10534-019-00197-1. Epub 2019 May 1. Biometals. 2019. PMID: 31044334 Free PMC article. Review.
Cited by
-
Detection and characterization of endogenous protease associated with desquamation of stratum corneum.Arch Dermatol Res. 1993;285(6):372-7. doi: 10.1007/BF00371839. Arch Dermatol Res. 1993. PMID: 8215586
-
Factors affecting germination of Trichophyton mentagrophytes arthrospores.Infect Immun. 1977 Nov;18(2):479-86. doi: 10.1128/iai.18.2.479-486.1977. Infect Immun. 1977. PMID: 21851 Free PMC article.
-
Human skin proteases. Fractionation of psoriasis scale proteases and separation of a plasminogen activator and a histone hydrolysing protease.Arch Dermatol Res (1975). 1976 Aug 27;256(2):113-26. doi: 10.1007/BF00567358. Arch Dermatol Res (1975). 1976. PMID: 9031
-
Lymphocyte stimulation in vitro by proteinases and its augmentation with a proteinase binding factor from human skin.Arch Dermatol Res. 1978 Nov 10;263(2):223-6. doi: 10.1007/BF00446444. Arch Dermatol Res. 1978. PMID: 736607 No abstract available.
-
Human Antimicrobial Peptides in Bodily Fluids: Current Knowledge and Therapeutic Perspectives in the Postantibiotic Era.Med Res Rev. 2018 Jan;38(1):101-146. doi: 10.1002/med.21435. Epub 2017 Jan 17. Med Res Rev. 2018. PMID: 28094448 Free PMC article. Review.